Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
31.98
+0.12 (0.38%)
At close: Jun 27, 2025, 4:00 PM
32.00
+0.02 (0.06%)
After-hours: Jun 27, 2025, 7:53 PM EDT
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts that cover HRMY stock have a consensus rating of "Strong Buy" and an average price target of $54.22, which forecasts a 69.54% increase in the stock price over the next year. The lowest target is $40 and the highest is $70.
Price Target: $54.22 (+69.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $61 | Buy | Initiates | $61 | +90.74% | Jun 2, 2025 |
| Mizuho | Mizuho | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +50.09% | May 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +53.22% | May 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +53.22% | May 6, 2025 |
| UBS | UBS | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +50.09% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
858.43M
from 714.73M
Increased by 20.10%
Revenue Next Year
1.01B
from 858.43M
Increased by 18.01%
EPS This Year
3.36
from 2.51
Increased by 33.80%
EPS Next Year
4.10
from 3.36
Increased by 22.13%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 898.1M | 1.1B | 1.4B | ||
| Avg | 858.4M | 1.0B | 1.2B | ||
| Low | 809.6M | 915.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.7% | 28.3% | 38.7% | ||
| Avg | 20.1% | 18.0% | 19.9% | ||
| Low | 13.3% | 6.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.19 | 5.24 | 7.81 | ||
| Avg | 3.36 | 4.10 | 5.38 | ||
| Low | 2.16 | 2.79 | 3.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 66.9% | 56.0% | 90.5% | ||
| Avg | 33.8% | 22.1% | 31.1% | ||
| Low | -14.1% | -16.8% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.